Drug Type Degradable Molecular Glue |
Synonyms BMS 986470, BMS986470 |
Target |
Action modulators, degraders |
Mechanism CRBN modulators(Cereblon modulators), WIZ degraders(WIZ zinc finger degraders), ZBTB7A degraders(zinc finger and BTB domain containing 7A degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Phase 2 | United States | 17 Jul 2024 | |
Anemia, Sickle Cell | Phase 2 | France | 17 Jul 2024 | |
Anemia, Sickle Cell | Phase 2 | United Kingdom | 17 Jul 2024 |